Publikacje

Central effects of Ro 19-6327 given acutely and repeatedly. G Skuza, Z Rogóz
Polish journal of pharmacology and pharmacy,
PMID:1668212
Piątek, 7 Sierpnia 1992
Serotonin, dopamine, noradrenaline and their metabolites: levels in the brain of the house cricket (Acheta domesticus L.) during a 24-hour period and after administration of quipazine--a 5-HT2 receptor agonist. E Pyza, K Gołembiowska, L Antkiewicz-Michaluk
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
PMID:1687530
Czwartek, 18 Czerwca 1992
The effect of (+)- and (-)-oxaprotiline administered repeatedly on the dopamine system. J Maj, V Klimek, Z Rogóz, G Skuza, H Sowińska
Journal of neural transmission. General section,
PMID:1751026
Piątek, 24 Stycznia 1992
Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats. J Maj, Z Rogóz, G Skuza
Journal of neural transmission. General section,
PMID:1930880
Poniedziałek, 23 Grudnia 1991
Involvement of 5-HT1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats. E Chojnacka-Wójcik, E Tatarczyńska, K Gołembiowska, E Przegaliński
Neuropharmacology,
PMID:1681449
Poniedziałek, 4 Listopada 1991
The role of dopamine in regulation of thyrotropin-releasing hormone in the striatum and nucleus accumbens of the rat. E Przegaliński, L Jaworska, R Konarska, K Gołembiowska
Neuropeptides,
PMID:1680223
Środa, 23 Października 1991
Some central effects of opipramol given repeatedly. G Skuza, Z Rogóz, H Sowińska
Polish journal of pharmacology and pharmacy,
PMID:2098752
Środa, 31 Lipca 1991
Ipsapirone, a new anxiolytic drug, stimulates catecholamine turnover in various regions of the rat brain. K Gołembiowska
Polish journal of pharmacology and pharmacy,
PMID:1980361
Czwartek, 28 Lutego 1991
The effect of fenfluramine on the thyrotropin-releasing hormone (TRH) content in the rat brain structures and lumbar spinal cord. E Przegaliński, L Jaworska, K Gołembiowska
Neuropeptides,
PMID:2124333
Czwartek, 31 Stycznia 1991
Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease. J Maj, Z Rogóz, G Skuza, H Sowińska, J Superata
Journal of neural transmission. Parkinson's disease and dementia section,
PMID:1977408
Czwartek, 13 Grudnia 1990